The expert source of drug information in palliative and hospice care
The Palliative Care Formulary provides unrivalled and expert drug information for health professionals when caring for adult patients facing progressive life-limiting diseases. This trusted source goes beyond standard references providing health professionals with in-depth and practical guidance on drugs and treatment regimens to help improve quality of life.
SubscribeContent Updates
Internationally acclaimed with over 20 years of unrivalled in-depth knowledge
Independent information on general and specialist drug use in palliative care
Comprehensive guidance for use across all stages of the patient journey
Rigorously researched information grounded firmly in everyday clinical practice
This update contains 2 revised monographs.
The following monographs have undergone minor revision: Inhaled long-acting β2 agonists (LABAs); Strong opioids.
This update contains 2 revised monographs.
The following monographs have been fully revised: Cerumenolytics; Drugs for oral inflammation and ulceration.
This update contains 4 revised monographs and a revision to the preface.
The following monographs have been fully revised: Artificial saliva; Continuous subcutaneous drug infusions; Oral nutritional supplements; Pilocarpine.
This update contains 1 new monograph, 22 revised monographs and 6 discontinued monographs. Editorial Staff was a new monograph for this update.
The following monographs have been fully revised:
Abbreviations; Anaphylaxis; Barrier products; Demeclocycline; Drug-induced movement disorders; Drugs for pruritus; Emollients; *Ketamine; Nebulized drugs; Obtaining specials; *Octreotide; Potassium; Prescribing in children; Prescribing in palliative care; Systemic corticosteroids; Taking controlled and prescription drugs to other countries; Topical antipruritics; Urinary tract infections; Variability in response to drugs.
The following monographs have undergone minor revision:
Getting the most out of PCF; How PCF is constructed; Prolongation of the QT interval in palliative care.
The following monographs have been discontinued:
Cardiovascular system (introductory paragraph); Clostridium difficile infection; Flurbiprofen; Nabumetone; Orphenadrine; Prochlorperazine.
This update contains 1 new monograph and 44 revised monographs. Parecoxib is a new monograph for this update.
The following monographs have been fully revised: *Cannabinoids; *Ketorolac trometamol; Antibacterials in palliative care; Anti-emetics; Antipsychotics; Baclofen; Bronchodilators; Celecoxib; Cellulitis in a lymphoedematous limb; Dantrolene; Diclofenac sodium; Drugs for cough; Ibuprofen; Magnesium; Medicinal products off-label; Mouthwashes; NSAIDs; Opioid antagonists – outside the CNS; Oral candidosis; Oxygen; QCG – Cellulitis in lymphoedema; QCG – Inoperable bowel obstruction; QCG – Reversal of opioid-induced respiratory depression; Rifampicin; Skeletal muscle relaxants; Tizanidine.
The following monographs have undergone minor revision: *Alfentanil; *Methadone; Buprenorphine; Depot corticosteroid injections; Diamorphine; Fentanyl; Fentanyl (transmucosal); Hydromorphone; Morphine; Opioid antagonists – within the CNS; Oxycodone; Paracetamol; Principles of use of analgesics; QCG – Use of methadone; Rubefacients; Strong opioids; Tapentadol; Theophylline.
This update contains 33 revised monographs.
The following monographs have been fully revised: 5HT3 antagonists; Anticoagulants; Antitussives; Clonidine; Cyclizine; Domperidone; Glyceryl trinitrate; Haloperidol; Inhaled corticosteroids; Inhaled long-acting ß2 agonists (LABAs); Ipratropium bromide; Levomepromazine; Low molecular weight heparin (LMWH); Metoclopramide; Mucolytics (oral); Naproxen; Nefopam; Nifedipine; Olanzapine; Quick Clinical Guide: Heparin-induced thrombocytopenia (HIT); Quick Clinical Guide: Nausea and vomiting; Quick Clinical Guide: Vertigo; Quetiapine; Risperidone; Salbutamol; Systemic local anaesthetics; Theophylline; Tiotropium
The following monographs have undergone minor revision: Psychostimulants; Quick Clinical Guide: Procedure-related pain; Thalidomide; Trazodone; Venlafaxine
